DBal Max Introduces Legal Dianabol Pills for Muscle Growth: A Safe Steroid Now Available in USA
DBal Max's new legal steroid is designed for fitness enthusiasts, competitive athletes, and bodybuilders who want explosive muscle growth, greater strength, and rapid recovery—without the health risks or legal worries of traditional steroids.
Product Launch: DBal Max Legal Dianabol Pills Hit the Market in USA
DBal Max, a premium sports nutrition and performance brand based in London, UK, has officially introduced its legal Dianabol pills for sale in the USA and worldwide.
This innovative supplement harnesses the muscle-building power of classic anabolic steroids—namely Dianabol (Dbol)—but with a formula composed entirely of natural, non-prescription ingredients.
Launch Date & Availability:DBal Max's legal Dianabol pills are available for purchase as of June 24, 2025. The product can be ordered directly through the official website at https://dbalmax.com, with global shipping available to most countries.Pricing Details:DBal Max is currently offering several pricing tiers to suit various budgets and fitness goals:
1 Month Supply: $68.95 per bottle (90 capsules)
3 Month Supply: $139.95 (includes 2 bottles + 1 free, saving $97)
6 Month Supply: $279.85 (includes 4 bottles + 2 free, saving $242) Bulk orders include free shipping and access to exclusive online resources for optimal results.
View official website for latest pricing and promotions
Main Product Benefits and Features: What Sets DBal Max Apart
DBal Max is engineered for athletes and bodybuilders who want real results—without compromising on safety or legality. Unlike anabolic steroids, which are controlled substances with serious health risks, DBal Max is made from natural, research-backed ingredients and manufactured in GMP-certified facilities.
Key Benefits:
Explosive Muscle Growth: Supercharges muscle protein synthesis, leading to faster and more substantial muscle gains.
Increased Strength: Helps users lift heavier, train harder, and achieve new personal bests.
Accelerated Recovery: Reduces post-workout fatigue and muscle soreness for quicker turnaround between sessions.
Fat Loss Support: Promotes a leaner, more defined physique by supporting fat metabolism.
All-Natural & Legal: 100% legal—no prescription required, zero synthetic steroids, and compliant with international supplement laws.
No Need for Post-Cycle Therapy (PCT): Unlike steroids, DBal Max doesn't suppress natural testosterone or disrupt hormone balance.
Core Ingredients:
Pro BCAA Complex: Essential for reducing muscle soreness and promoting growth.
20-Hydroxyecdysterone: A plant-based compound shown to increase muscle ATP and protein synthesis.
Whey Protein Complex: Fuels muscle repair and growth.
Ashwagandha, Tribulus Terrestris, and other adaptogens: Support energy, testosterone, and recovery.
Health & Safety Benefits: Why Choose a Legal Alternative?
The dangers of traditional anabolic steroids like Dianabol and dbol are well-documented—ranging from liver toxicity and hormonal imbalance to high blood pressure, hair loss, and even legal prosecution. DBal Max was created as a direct response to these widespread risks, offering a safer alternative for muscle growth.
Safety Certifications & Testing:
Manufactured in GMP-certified facilities: Ensuring pharmaceutical-grade quality and safety.
Third-party batch testing: Verifies ingredient purity and consistency.
No banned substances: DBal Max contains no hormones, controlled substances, or ingredients banned by major sporting organizations.
No Prescription Required: DBal Max is available for over-the-counter purchase, making it accessible to athletes and fitness enthusiasts without the need for a doctor's approval or risk of legal complications.
Scientific Innovation: The Research Behind DBal Max
DBal Max's formula is built on modern exercise science and clinical research into muscle growth and athletic performance.
Key Scientific Principles:
Protein Synthesis: The Pro BCAA Complex and 20-Hydroxyecdysterone work synergistically to stimulate muscle protein synthesis, mimicking the anabolic environment created by steroids—but safely and naturally.
Nitrogen Retention: Whey protein and BCAAs help muscles retain more nitrogen, a key driver for sustained muscle growth.
ATP Production: 20-Hydroxyecdysterone has been shown in studies to increase intracellular ATP, supporting higher-intensity workouts and faster muscle recovery.
Stress Response & Adaptation: Adaptogenic botanicals like ashwagandha help regulate cortisol (the stress hormone), supporting better testosterone balance and recovery.
Supporting Studies:
20-Hydroxyecdysterone: Clinical research, including a study published in the Journal of the International Society of Sports Nutrition, found that ecdysteroids can significantly increase muscle mass and strength in humans—without androgenic side effects.
BCAAs: Multiple studies confirm BCAAs' role in reducing muscle soreness, supporting recovery, and improving muscle endurance.
Ashwagandha: Peer-reviewed research shows that ashwagandha supplementation can improve strength, muscle mass, and testosterone in resistance-trained men.
Market Disruption: Changing the Game in Sports Nutrition
The launch of DBal Max's legal Dianabol pills marks a turning point for the muscle-building supplement market. Until now, athletes and bodybuilders faced a difficult choice: accept the health and legal risks of steroids, or settle for less effective, generic supplements.
DBal Max disrupts this landscape by offering powerful, safe, and legal muscle-building results—bridging the gap between science, efficacy, and accessibility.
Quote from Company Spokesperson:
'With the introduction of our legal Dianabol pills, DBal Max is empowering athletes and fitness enthusiasts to pursue their goals without compromise. Our mission is to make world-class muscle-building results accessible, safe, and legal for everyone,' said James Franklin, Chief Product Officer at DBal Max. 'This launch is the result of years of research and development, and we're excited to help our customers break through their plateaus—safely and naturally.'
Consumer Benefits: Real Results Without the Risks
DBal Max is engineered for everyone—from competitive athletes and serious bodybuilders to everyday gym-goers and fitness newcomers. Users can expect:
Visible Muscle Growth: Most see changes in muscle size and definition within 4–8 weeks of consistent use, as part of a resistance training program.
Faster Strength Gains: Many report significant increases in bench press, squat, and deadlift numbers compared to baseline.
No Side Effects: Because DBal Max uses only natural, non-hormonal ingredients, users do not experience the common side effects of steroids—like acne, hair loss, liver strain, or mood swings.
No Legal Risk: DBal Max is available worldwide and is fully compliant with supplement laws—no prescription, no banned substances, no worries.
No Post-Cycle Recovery Needed: Users can take DBal Max continuously during their training cycles without the need for complicated hormonal recovery protocols.
Distribution Channels: How and Where to Buy
DBal Max is available exclusively through its official website at https://dbalmax.com. This direct-to-consumer approach ensures product authenticity, competitive pricing, and access to all available discounts and bonuses.
Global Shipping: DBal Max ships to North America, Europe, Australia, Asia, and many other regions. Expedited shipping options and discreet packaging are available on all orders.
Customer Support: Every purchase includes lifetime access to DBal Max's dedicated customer support team, available via email, live chat, or phone.
Company and Contact Information
Company Name: DBal Max Headquarters: London, United Kingdom Website: https://dbalmax.com Contact Person: James Franklin, Chief Product Officer Media Contact Email: support@dbalmax.com Press Inquiries Phone: +44 20 1234 5678 Manufacturing: Produced in certified GMP facilities for safety and quality
The Future of Muscle Growth Is Here—Safe, Legal, and Effective
With the launch of its legal Dianabol pills in the United States, DBal Max is delivering on the promise of real muscle-building power of Dbol pills without the dangers of traditional steroids. Athletes and fitness enthusiasts worldwide can now pursue world-class gains, knowing that their health and compliance are never in jeopardy.
DBal Max stands at the intersection of scientific innovation, consumer safety, and performance nutrition—offering a new standard for supplements in 2025 and beyond.
For more information, to view clinical data, or to purchase DBal Max, visit the official USA website.
About DBal MaxDBal Max is a leading sports nutrition brand headquartered in London, specializing in science-driven, legal performance supplements for muscle growth, fat loss, and athletic recovery. All products are made from premium natural ingredients, supported by clinical research, and manufactured to the highest international safety standards.Media Contact:James Franklin, Chief Product Officer DBal Max Email: support@dbalmax.com Phone: +44 20 1234 5678 Website: https://dbalmax.com London, United KingdomAttachment
dbalmax
CONTACT: Company Name: DBal Max Headquarters: London, United Kingdom Website: https://dbalmax.com Contact Person: James Franklin, Chief Product Officer Media Contact Email: support@dbalmax.com Press Inquiries Phone: +44 20 1234 5678 Manufacturing: Produced in certified GMP facilities for safety and quality
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
4 hours ago
- Business Upturn
LEADING EDGE MATERIALS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT
By GlobeNewswire Published on August 16, 2025, 02:30 IST LEADING EDGE MATERIALS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN LEADING EDGE MATERIALS IN ANY JURISDICTION. Vancouver, August 15, 2025 – Leading Edge Materials Corp. ('Leading Edge Materials' or the 'Company') (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces announce the closing of the non-brokered private placement financing (the 'Private Placement') previously announced on June 10, 2025. Pursuant to the Private Placement, the Company has issued 17,738,500 units (the 'Units') at a price of C$0.16 per Unit for aggregate gross proceeds of C$2,838,160. Each Unit consists of one (1) common share (each, a 'Common Share') in the capital of the Company and one (1) Common Share purchase warrant (a 'Warrant'). Each Warrant will entitle the holder to purchase one Common Share (a 'Warrant Share') at a price of C$0.32 per Warrant Share until the date which is four (4) years from the closing date of the Private Placement (the 'Closing Date'). Leading Edge Materials intends to use net proceeds for the Company's projects, located in Sweden and Romania and for general working capital and corporate purposes. A finder's fee of 6% was paid to arm's length third party on a portion of the Private Placement. The Private Placement is subject to final approval from the TSX Venture Exchange (the 'Exchange'). The securities issued pursuant to the Private Placement are subject to applicable statutory resale restrictions, including a hold period expiring on December 15, 2025, pursuant to applicable Canadian securities laws. Insiders of the Company purchased a total of 10,666,000 Units under the Private Placement which constitutes a 'related party transaction' as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ('MI 61-101'). The Company relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 based on the fact that neither the fair market value of the Units subscribed for by the insiders, nor the consideration for the Units paid by such insiders, exceeded 25% of the Company's market capitalization as determined in accordance with MI 61-101. Mr. Eric Krafft, a director of the Company, has subscribed for and acquired 10,666,000 Common Shares under the Private Placement. Prior to the Private Placement, Mr. Krafft beneficially owned and controlled 85,056,577 Common Shares and 22,852,173 warrants of the Company. Mr. Krafft is a Control Person (as defined by the policies of the Exchange), beneficially holding 95,722,577 common shares and 33,518,173 warrants of the Company, representing approximately 38.30% of the issued and outstanding Common Shares on a non-diluted basis, and 48.28% on a partially diluted basis, assuming the exercise of warrants held by Mr. Krafft only. The Company obtained disinterested shareholder approval at the Annual General Meeting held on July 24, 2020 for Mr. Krafft to become a Control Person of the Company. Eric Krafft has acquired the Units for investment purposes and has a long-term view of his investment. In the future, Mr. Krafft may take such actions in respect of his investment in the Company as he may deem appropriate, depending on the market conditions and circumstances at that time. The foregoing disclosure regarding Mr. Krafft's holdings is being disseminated pursuant to National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues (NI 62-103). A copy of Mr. Krafft's early warning report will appear on the Company's profile on SEDAR Plus. The information herein with respect to the number of Mr. Krafft's securities and his intention relating thereto are not within the knowledge of the Company and are provided by Mr. Krafft. The securities have not been, and will not be, registered under the U.S. Securities Act, or any United States state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable United States state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. This news release is not a prospectus under Regulation (EU) 2017/1129 (the 'EU Prospectus Regulation'). The Company has not authorized any offer of securities to the public (as defined in the EU Prospectus Regulation) in any EEA member state and no such prospectus has been or will be prepared in connection with the Private Placement. On behalf of the Board of Directors, Leading Edge Materials Corp. Kurt Budge, CEO For further information, please contact the Company at: [email protected] Follow usTwitter: Linkedin: About Leading Edge Materials Leading Edge Materials is a Canadian public company focused on developing a portfolio of critical raw material projects located in the European Union. Critical raw materials are determined as such by the European Union based on their economic importance and supply risk. They are directly linked to high growth technologies such as lithium-ion batteries and permanent magnets for electric motors, wind turbines and defense applications. The portfolio of projects includes the 100% owned Woxna Graphite mine (Sweden), 100% owned Norra Kärr Heavy Rare Earth Elements project (Sweden) and the 51% owned Bihor Sud Nickel Cobalt exploration alliance (Romania). Additional Information This information is information that Leading Edge Materials Corp. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, at August 15, 2025 at 2:30 PM Vancouver time. Leading Edge Materials is listed on the TSXV under the symbol 'LEM', OTCQB under the symbol 'LEMIF' and Nasdaq First North Stockholm under the symbol 'LEMSE'. Svensk Kapitalmarknadsgranskning ('SKMG') is the Company's Certified Adviser for the Nasdaq First North Growth Market (Stockholm) and may be contacted via email [email protected] or by phone +46 (0)8 913 008. Reader Advisory This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Leading Edge Materials in any jurisdiction. This news release may include forward-looking information that is subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking, including statements with respect to the closing of the Private Placement, the receipt of regulatory approvals, and the use of proceeds from the Private Placement. Although the Company believes the expectations expressed in such forward-looking information are based on reasonable assumptions, such information is not a guarantee of future performance and actual results or developments may differ materially from those contained in forward-looking information. Factors that could cause actual results to differ materially from those in forward-looking information include, but are not limited to, fluctuations in market prices, successes of the operations of the Company, the Company's ability to close the Private Placement, the Company's ability to obtain the required regulatory approvals, continued availability of capital and financing and general economic, market or business conditions. There can be no assurances that such information will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. The Company does not assume any obligation to update any forward-looking information except as required under the applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Important information for EEA Investors The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Leading Edge Materials in any jurisdiction. Any investment decision in connection with the Private Placement must be made on the basis of all publicly available information relating to the Company and the Company's shares/Units. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in the Company or the new shares/Units. This press release is not a prospectus for the purposes of the EU Prospectus Regulation. Leading Edge Materials has not authorized any offer to the public of Units, shares or rights in any member state of the EEA and no prospectus has been or will be prepared in connection with the Private Placement. In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, 'qualified investors' who are (i) persons having professional experience in matters relating to investments who fall within the definition of 'investment professionals' in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Order'); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as 'relevant persons'). In the United Kingdom, any investment or investment activity to which this communication relates is available only to, and will be engaged in only with, relevant persons. Persons who are not relevant persons should not take any action on the basis of this document and should not act or rely on it. Attachment LEM – 2025 News Release Annoucing Closing of Financing-final Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
4 hours ago
- Business Upturn
Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements
Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — Youxin Technology Ltd (Nasdaq: YAAS) (the 'Company' or 'Youxin Technology'), a software as a service ('SaaS') and platform as a service ('PaaS') provider committed to helping retail enterprises digitally transform their businesses, today announced that it received two staff determination notices (the 'Notice(s)') from the Listings Qualifications Department of The Nasdaq Stock Market LLC ('Nasdaq') on August 13, 2025. The Notices notify the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq, and pursuant to Listing Rule 5550(b)(2), it is required to maintain a minimum Market Value of Listed Securities ('MVLS') of $35 million for continued listing on the Nasdaq Capital Market (the 'MVLS Requirement'). This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification. The Notices have no immediate effect on the listing of the Company's Class A ordinary shares, which will continue to trade uninterrupted on Nasdaq under the ticker 'YAAS'. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until February 9, 2026 (the 'Bid Price Compliance Period'), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Bid Price Compliance Period, the closing bid price per share of the Company's Class A ordinary shares is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with the minimum bid price requirement by February 9, 2026, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary. Pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company has a compliance period of 180 calendar days, or until February 9, 2026 (the 'MVLS Compliance Period'), to regain compliance with Nasdaq's MVLS Requirement. If at any time during the MVLS Compliance Period, the Company's MVLS is at least $35 million for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. If the Company fails to regain compliance within the MVLS Compliance Period, the Company would have the right to a hearing before an independent panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process. The Company's business operations are not affected by the receipt of the Notices. The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and to remain listed on Nasdaq. About Youxin Technology Ltd Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses using its cloud-based SaaS product and PaaS platform to develop, use and control business applications without the need to purchase complex IT infrastructure. Youxin Technology provides a customized, comprehensive, fast-deployment omnichannel digital solutions that unify all aspects of commerce with store innovations, distributed inventory management, cross-channel data integration, and a rich set of ecommerce capabilities that encompass mobile applications, social media, and web-based applications. The Company's products allow mid-tier brand retailers to use offline direct distribution to connect the management team, distributors, salespersons, stores, and end customers across systems, apps, and devices. This provides retailers with a comprehensive suite of tools to instantly address issues using real-time sales data. For more information, please visit the Company's website: Forward-Looking Statements Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as 'approximates,' 'assesses,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC. References and links (including QR codes) to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. For more information, please contact: Youxin Technology Relations Department Email: [email protected]
Business Upturn
4 hours ago
- Business Upturn
DIFD AUTO Reshapes the Global Car Buying Landscape – Cryptocurrency Payments + Limited-Time Offer
London, United Kingdom, Aug. 15, 2025 (GLOBE NEWSWIRE) — In today's rapidly evolving digital asset era, DIFD AUTO is leading the global cryptocurrency car buying revolution. As the world's leading cryptocurrency-based car trading platform, DIFD AUTO enables customers worldwide to purchase 100% brand-new, authentic cars using major cryptocurrencies like BTC, ETH, and USDT, offering a game-changing experience in pricing, process, and after-sales service. Limited-Time Exclusive Offer: Up to 30% off car purchases (select models only) New customers can receive up to $5,000 in vehicle credit (deductible directly from the purchase price) Bulk purchase discounts – up to 30% off for 3 or more vehicles Partner commission rebates of 10% to 30% 5 years of free support and maintenance Zero transaction fees and brokerage fees Why choose DIFD AUTO? Free and convenient cryptocurrency payments Instant global transfers without cumbersome banking procedures Secure and transparent blockchain transactions One-stop global logistics services International shipping and full container load (FCL) options Comprehensive customs clearance, insurance, and compliance services Worldwide door-to-door delivery With an export network spanning five continents Strong partnerships with international dealers and luxury car brands Multilingual customer support A dedicated team fluent in English, German, French, Arabic, and other languages Industry Trend: Buying cars with cryptocurrency is becoming the new normal US Lamborghini dealers have accepted Bitcoin since 2013 (CNBC report) Ferrari expands support for Bitcoin, Ethereum, and the US dollar ( AutoCoinCars data: The global cryptocurrency car purchase market is expected to reach $1.2 trillion by 2024. Blockchain Reform: 42 Million Car Ownership Records on-chain to Combat Fraud. DIFD AUTO's Unique Advantages * 100% new certified vehicles with traceable quality * Worldwide shipping, including customs clearance and insurance * Transparent pricing, save up to 30% * Fast, secure, and affordable cryptocurrency settlement Limited-time offer—first come, first served! Whether you're in Europe, the Americas, the Middle East, Africa, Asia, or Latin America—Choose your vehicle → Pay with cryptocurrency → Deliver to your door—and let DIFD AUTO do the rest. Sign up now to receive up to $5,000 in vehicle credit and enjoy exclusive global pricing and best-selling models! Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
